Suppr超能文献

COVID-19 疫苗犹豫:系统评价和荟萃分析的伞式综述。

COVID-19 Vaccine Hesitancy: Umbrella Review of Systematic Reviews and Meta-Analysis.

机构信息

Molecular Toxicology and Genetics, Riyadh Elm University, Riyadh, Saudi Arabia.

Center for Global Health Research, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India.

出版信息

JMIR Public Health Surveill. 2024 Apr 30;10:e54769. doi: 10.2196/54769.

Abstract

BACKGROUND

The unprecedented emergence of the COVID-19 pandemic necessitated the development and global distribution of vaccines, making the understanding of global vaccine acceptance and hesitancy crucial to overcoming barriers to vaccination and achieving widespread immunization.

OBJECTIVE

This umbrella review synthesizes findings from systematic reviews and meta-analyses to provide insights into global perceptions on COVID-19 vaccine acceptance and hesitancy across diverse populations and regions.

METHODS

We conducted a literature search across major databases to identify systematic reviews and meta-analysis that reported COVID-19 vaccine acceptance and hesitancy. The AMSTAR-2 (A Measurement Tool to Assess Systematic Reviews) criteria were used to assess the methodological quality of included systematic reviews. Meta-analysis was performed using STATA 17 with a random effect model. The data synthesis is presented in a table format and via a narrative.

RESULTS

Our inclusion criteria were met by 78 meta-analyses published between 2021 and 2023. Our analysis revealed a moderate vaccine acceptance rate of 63% (95% CI 0.60%-0.67%) in the general population, with significant heterogeneity (I = 97.59%). Higher acceptance rates were observed among health care workers and individuals with chronic diseases, at 64% (95% CI 0.57%-0.71%) and 69% (95% CI 0.61%-0.76%), respectively. However, lower acceptance was noted among pregnant women, at 48% (95% CI 0.42%-0.53%), and parents consenting for their children, at 61.29% (95% CI 0.56%-0.67%). The pooled vaccine hesitancy rate was 32% (95% CI 0.25%-0.39%) in the general population. The quality assessment revealed 19 high-quality, 38 moderate-quality, 15 low-quality, and 6 critically low-quality meta-analyses.

CONCLUSIONS

This review revealed the presence of vaccine hesitancy globally, emphasizing the necessity for population-specific, culturally sensitive interventions and clear, credible information dissemination to foster vaccine acceptance. The observed disparities accentuate the need for continuous research to understand evolving vaccine perceptions and to address the unique concerns and needs of diverse populations, thereby aiding in the formulation of effective and inclusive vaccination strategies.

TRIAL REGISTRATION

PROSPERO CRD42023468363; https://tinyurl.com/2p9kv9cr.

摘要

背景

COVID-19 大流行的空前出现促使疫苗的开发和全球分发,因此了解全球对 COVID-19 疫苗的接受度和犹豫程度对于克服接种障碍和实现广泛免疫至关重要。

目的

本伞状评价综合了系统评价和荟萃分析的结果,提供了对不同人群和地区对 COVID-19 疫苗接受度和犹豫度的全球看法的见解。

方法

我们对主要数据库进行了文献检索,以确定报告 COVID-19 疫苗接受度和犹豫度的系统评价和荟萃分析。使用 AMSTAR-2(评估系统评价的测量工具)标准评估纳入系统评价的方法学质量。使用 STATA 17 进行随机效应模型的荟萃分析。数据综合以表格形式和叙述形式呈现。

结果

我们的纳入标准符合 2021 年至 2023 年期间发表的 78 项荟萃分析。我们的分析显示,一般人群中疫苗接受率为 63%(95%CI 0.60%-0.67%),存在显著异质性(I = 97.59%)。医护人员和患有慢性病的人群的接受率更高,分别为 64%(95%CI 0.57%-0.71%)和 69%(95%CI 0.61%-0.76%)。然而,孕妇的接受率较低,为 48%(95%CI 0.42%-0.53%),父母同意为孩子接种疫苗的接受率为 61.29%(95%CI 0.56%-0.67%)。一般人群中疫苗犹豫率为 32%(95%CI 0.25%-0.39%)。质量评估显示,有 19 项高质量、38 项中等质量、15 项低质量和 6 项极低质量的荟萃分析。

结论

本综述揭示了全球范围内存在疫苗犹豫,强调需要针对特定人群、具有文化敏感性的干预措施,以及清晰、可信的信息传播,以促进疫苗接种。观察到的差异突出表明需要持续研究,以了解不断变化的疫苗认知,并解决不同人群的独特关注和需求,从而有助于制定有效和包容的疫苗接种策略。

试验注册

PROSPERO CRD42023468363;https://tinyurl.com/2p9kv9cr。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1071/11062401/49764eb40622/publichealth_v10i1e54769_fig1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验